Showing 3661-3670 of 10623 results for "".
IBD: A Journey from Parent to Advocate
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/ibd-journey-from-parent-to-advocate/10343/Learning your child has been diagnosed with IBD is never easy. Listen to how one parent turned it into an opportunity to help other IBD patients.COPD and Cardiovascular Risk: The Expanding Role of Biomarkers
https://reachmd.com/programs/clinicians-roundtable/copd-cardiovascular-risk-biomarkers/54184/Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
https://reachmd.com/programs/heart-matters/heart-failure-mortality-cardiac-amyloidosis/49064/The GLP-1 Stress Test: Where the Liquid Facelift Hits the Wall
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/the-glp-1-stress-test-where-the-liquid-facelift-hits-the-wall/54421/Women in Aesthetics: Fairyal Day
https://reachmd.com/topics/practice-development/women-in-aesthetics-fairyal-day/48886/Get to know Fairyal Day, Founder of Med Talent, Global Medical Search, an executive search firm specializing in the medical aesthetics, dermatology, dental, and pharmaceutical industriesShould Children and Adolescents Be Screened for Primary Hyperhidrosis?
https://reachmd.com/topics/rare-disease/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/39946/Lifestyle Intervention and Bone Quality in Older Adults with Obesity
https://reachmd.com/programs/clinicians-roundtable/program-name/39653/ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
https://reachmd.com/programs/neurofrontiers/asd-in-children-with-sma-type-i-diagnostic-challenges-in-a-multifactorial-context/36613/Analyzing Outpatient Worsening Heart Failure in ATTR-CM
https://reachmd.com/programs/heart-matters/analyzing-outpatient-worsening-heart-failure-in-attr-cm/36138/NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
https://reachmd.com/programs/neurofrontiers/nkx019-a-potential-new-frontier-in-generalized-myasthenia-gravis-therapy/30066/Read about NKX019, a new CAR cell therapy that will soon enter clinical trials as a potential treatment for generalized myasthenia gravis.